Literature DB >> 15858107

Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis.

Tim Leiner1, Alphons G H Kessels, Patricia J Nelemans, G Boudewijn C Vasbinder, Michiel W de Haan, Peter E J H M Kitslaar, Kai Yiu J A M Ho, Jan H M Tordoir, Joseph M A van Engelshoven.   

Abstract

PURPOSE: To prospectively compare the diagnostic accuracies of color duplex ultrasonography (US) and contrast material-enhanced magnetic resonance (MR) angiography and to assess interobserver agreement regarding contrast-enhanced MR angiographic findings in patients suspected of having peripheral arterial disease (PAD).
MATERIALS AND METHODS: The institutional review board approved the study, and all patients provided signed informed consent. Two hundred ninety-five patients referred for diagnostic and preinterventional work-up of PAD with duplex US also underwent gadolinium-enhanced MR angiography. Data sets were reviewed for presence or absence of 50% or greater luminal reduction, which indicated hemodynamically significant stenosis, and to determine interobserver agreement. At duplex US, a peak systolic velocity ratio of 2.5 or greater indicated significant stenosis. Primary outcome measures were differences between duplex US and contrast-enhanced MR angiography in sensitivity and specificity for detection of significant stenosis, as assessed with the McNemar test, and interobserver agreement between the two contrast-enhanced MR angiogram readings, expressed as quadratic weighted kappa values. Intraarterial digital subtraction angiography (DSA) was the reference standard.
RESULTS: Two hundred forty-nine patients had at least one hemodynamically significant stenotic lesion at contrast-enhanced MR angiography, duplex US, or both examinations. One hundred fifty-two patients underwent intraarterial DSA. The quadratic weighted kappa for agreement regarding the presence of 50% or greater stenosis at contrast-enhanced MR angiography was 0.89 (95% confidence interval [CI]: 0.87, 0.91). Sensitivity of duplex US was 76% (95% CI: 69%, 82%); specificity, 93% (95% CI: 91%, 95%); and accuracy, 89%. Sensitivity and specificity of contrast-enhanced MR angiography were 84% (95% CI: 78%, 89%) and 97% (95% CI: 95%, 98%), respectively; accuracy was 94%. Sensitivity (P = .002) and specificity (P = .03) of contrast-enhanced MR angiography were significantly higher.
CONCLUSION: Results of this prospective comparison between contrast-enhanced MR angiography and duplex US provide evidence that contrast-enhanced MR angiography is more sensitive and specific for diagnosis and preinterventional work-up of PAD. (c) RSNA, 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858107     DOI: 10.1148/radiol.2352040089

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  20 in total

1.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

Review 2.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Authors:  W Gregory Hundley; David A Bluemke; J Paul Finn; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Vincent B Ho; Michael Jerosch-Herold; Christopher M Kramer; Warren J Manning; Manesh Patel; Gerald M Pohost; Arthur E Stillman; Richard D White; Pamela K Woodard
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

3.  Ultrasound Contrast Agents in the Study of Kidney Function in Health and Disease.

Authors:  Kambiz Kalantarinia; Mark D Okusa
Journal:  Drug Discov Today Dis Mech       Date:  2007

Review 4.  Whole-Body MRA.

Authors:  Harald Kramer; Harald H Quick; Bernd Tombach; Stefan O Schoenberg; Joerg Barkhausen
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

5.  Variations in the popliteal artery branching in 342 patients studied with peripheral CT angiography using 64-MDCT.

Authors:  Cuneyt Calisir; Sevtap Simsek; Murat Tepe
Journal:  Jpn J Radiol       Date:  2014-11-26       Impact factor: 2.374

6.  Subtractionless first-pass single contrast medium dose peripheral MR angiography using two-point Dixon fat suppression.

Authors:  Tim Leiner; Jesse Habets; Bastiaan Versluis; Liesbeth Geerts; Eveline Alberts; Niels Blanken; Jeroen Hendrikse; Evert-Jan Vonken; Holger Eggers
Journal:  Eur Radiol       Date:  2013-04-17       Impact factor: 5.315

Review 7.  Diagnostic performance of computed tomography angiography and contrast-enhanced magnetic resonance angiography in patients with critical limb ischaemia and intermittent claudication: systematic review and meta-analysis.

Authors:  Sjoerd Jens; Mark J W Koelemay; Jim A Reekers; Shandra Bipat
Journal:  Eur Radiol       Date:  2013-06-26       Impact factor: 5.315

Review 8.  Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions.

Authors:  Amy W Pollak; Patrick T Norton; Christopher M Kramer
Journal:  Circ Cardiovasc Imaging       Date:  2012-11       Impact factor: 7.792

Review 9.  [Imaging of aortic disease].

Authors:  P Reimer; R Vosshenrich; P Landwehr; M Storck
Journal:  Radiologe       Date:  2007-05       Impact factor: 0.635

10.  Comparison of leg loader and treadmill exercise for evaluating patients with peripheral artery disease.

Authors:  Yasushi Ueki; Takashi Miura; Tomoaki Mochidome; Keisuke Senda; Soichiro Ebisawa; Tatsuya Saigusa; Hirohiko Motoki; Ayako Okada; Jun Koyama; Koichiro Kuwahara
Journal:  Heart Vessels       Date:  2018-10-04       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.